| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/28/2007 | WO2007047687A3 Compositions and methods for prolonging survival of platelets |
| 06/28/2007 | WO2007045252A3 An edible composition |
| 06/28/2007 | WO2007042040A3 TREATMENT OF RETINOPATHIES USING GFRα3 AGONISTS |
| 06/28/2007 | WO2007041645A3 Oxidized human bnp |
| 06/28/2007 | WO2007040550A3 Torc polynucleotides and polypeptides, and methods of use |
| 06/28/2007 | WO2007027614A3 Abnormal glycosylation in tamm-horsfall protein in interstitial cystitis patient |
| 06/28/2007 | WO2007021423A3 Gene disruptions, compositions and methods relating thereto |
| 06/28/2007 | WO2007018843A3 Methods and compositions for diagnosis and treatment of influenza |
| 06/28/2007 | WO2007014943A3 Therapy for neurological diseases |
| 06/28/2007 | WO2007014391A3 Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents |
| 06/28/2007 | WO2007014029A3 Yin yang 1 as a treatment for cardiac hypertrophy and heart failure |
| 06/28/2007 | WO2007009529A3 Calcium-peptide component |
| 06/28/2007 | WO2007008894A3 Cyclosporin compositions |
| 06/28/2007 | WO2007007362A3 Vegf-d and functional fragments thereof for bone repair |
| 06/28/2007 | WO2006136450A3 Supravalent compounds |
| 06/28/2007 | WO2006134340A3 Oxyntomodulin analogues and their effects on feeding behaviour |
| 06/28/2007 | WO2006132701A3 Methods and kits for regulation of microtubule assembly and dendrite growth and branching |
| 06/28/2007 | WO2006127642A3 Use of botulinum toxin for treating peritoneal adhesions |
| 06/28/2007 | WO2006122205A3 Conus californicus neurotoxins |
| 06/28/2007 | WO2006119062A3 Sclerostin epitopes |
| 06/28/2007 | WO2006110655A3 Compounds, compositions and methods for the treatment of poxvirus infections |
| 06/28/2007 | WO2006108651A3 Use of activin products for preventing and treating diabetes and/or metabolic syndrome |
| 06/28/2007 | WO2006090385A3 Protease inhibitors and method of screening thereof |
| 06/28/2007 | WO2006035439A3 Recombinant human t2 rnase and uses thereof |
| 06/28/2007 | WO2005118831A3 Polymeric compositions and related methods of use |
| 06/28/2007 | WO2005072419A3 Gastrointestinal proliferative factor and uses thereof |
| 06/28/2007 | WO2005040194A3 Methods and compositions for pdgf-c activation and inhibition |
| 06/28/2007 | WO2005027839A3 Methods and reagents for the treatment of immunoinflammatory disorders |
| 06/28/2007 | WO2004075850A3 Polyvalent immunogen |
| 06/28/2007 | WO2002083919A3 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 06/28/2007 | WO2002070701A9 Novel human gnrh receptor |
| 06/28/2007 | US20070150976 High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers |
| 06/28/2007 | US20070150972 Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses |
| 06/28/2007 | US20070150971 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 06/28/2007 | US20070149916 Dry matrices as drug reservoirs in electrotransport applications |
| 06/28/2007 | US20070149770 Poly zinc finger proteins with improved linkers |
| 06/28/2007 | US20070149769 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) |
| 06/28/2007 | US20070149767 Agent |
| 06/28/2007 | US20070149765 Liquid phase peptide syntheses of KL-4 pulmonary surfactant |
| 06/28/2007 | US20070149761 To evaluate the effectiveness of a compound to inhibit NS5B activity |
| 06/28/2007 | US20070149492 Method of affecting sleep and sleep-related behaviors |
| 06/28/2007 | US20070149483 Methods and compounds for modulating triglyceride and vldl secretion |
| 06/28/2007 | US20070149477 Stimulating a Th2 response by administering multivalent LNFPIII, an immunomodulatory glycan Lacto-N-Fucopentaose III, which contains the Lewis X trisaccharide (CD!%/antigen/); autoimmune disease; antidiabetic agents; antiarthritic agents; multiple sclerosis; colitis; psoriasis |
| 06/28/2007 | US20070149471 Gene expression inhibition using small interfering RNAs which are specific for the vascular endothelial growth factor (VEGF) gene and the VEGF receptor genes Flt-1 and Flk-1/KDR; diabetic retinopathy, age related macular degeneration and many types of cancer |
| 06/28/2007 | US20070149460 Modified lysine-mimetic compounds |
| 06/28/2007 | US20070149459 Oxidation of N-[3-amino-1-(cyclobutylmethyl)-2-hydroxy,3-oxopropyl]-3-{N-[(tert-butylamino)carbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide with an oxidizing agent selected from the group consisting of NaClO, Ca(OCl)2, and NaBrO3 |
| 06/28/2007 | US20070149458 Uses of myostatin antagonists |
| 06/28/2007 | US20070149457 Stable solid forms of enterostatin |
| 06/28/2007 | US20070149456 Epithelial sodium channel inhibiting agents and uses therefor |
| 06/28/2007 | US20070149455 Modified and stabilized gdf propeptides and uses thereof |
| 06/28/2007 | US20070149454 Controlled Release Delivery System for Nasal Applications and Method of Treatment |
| 06/28/2007 | US20070149453 Treating inflammation using a biological agent that causes cells to release cytokine receptors |
| 06/28/2007 | US20070149452 Method of Treating and/or Preventing Cancers and AIDS using Sartans and/or Statins to modulate VDR, and/or PPAR, and/or GCR and/or CB1 receptors; in conjunction with certain bacteriostatic antibiotics |
| 06/28/2007 | US20070149451 For example, vildagliptin and orlistat or phentermine |
| 06/28/2007 | US20070149450 Method for reducing levels of c-reactive protein |
| 06/28/2007 | US20070149449 Therapeutic targets in cancer |
| 06/28/2007 | US20070149448 chronic ulcers; cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media |
| 06/28/2007 | US20070149447 Mixture of Cyclosporin A, oil and surfactant |
| 06/28/2007 | US20070149446 Tamandarin analogs and fragments thereof and methods of making and using |
| 06/28/2007 | US20070149445 Aplidine for multiple myeloma treatment |
| 06/28/2007 | US20070149444 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 06/28/2007 | US20070149443 Methods of treating obesity using enterostatin |
| 06/28/2007 | US20070149442 Non-hygroscopic compositions of enterostatin |
| 06/28/2007 | US20070149441 Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
| 06/28/2007 | US20070149440 Transferrin and transferrin-based compositions for diabetes treatment |
| 06/28/2007 | US20070149439 Pituitary adenylate cyclase-activating polypeptide (PACAP) is an anti-mitogenic signal for selected neuronal precursors in vivo |
| 06/28/2007 | US20070148740 Chondroitinase ABC I and methods of degrading therewith |
| 06/28/2007 | US20070148739 amino acid substitutions at specific positions that confer increased relative activity in biological assays with reduced immunogenic potential in the protein; hepatitis C virus infection |
| 06/28/2007 | US20070148731 Expression control sequence cassette; a nucleotide sequence of a lac operator sequence to which a lacI repressor protein specifically binds a mutated lac; modification of the nucleotide sequence within a T5 promoter/lac operator expression control sequence provides a stable promoter/operator |
| 06/28/2007 | US20070148706 Pancreatic progenitor cells and methods for isolating the same |
| 06/28/2007 | US20070148689 Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases |
| 06/28/2007 | US20070148688 Novel human enzymes of the metalloprotease family |
| 06/28/2007 | US20070148680 Detection of disease related genes |
| 06/28/2007 | US20070148254 Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres |
| 06/28/2007 | US20070148228 Bioavailability; absorption; using a fatty acid, or salt thereof, or fatty ester ; sustained release; histone deacetylase inhibitor |
| 06/28/2007 | US20070148214 Wound dressing for the controlled release of therapeutic agents |
| 06/28/2007 | US20070148199 Preparations for topical skin use and treatment |
| 06/28/2007 | US20070148189 Stable Liquid Formulations of Botulinum Toxin |
| 06/28/2007 | US20070148184 Survivin-derived peptides and use thereof |
| 06/28/2007 | US20070148175 Diagnostics and therapeutics for diseases associated with kallikrein 12 (klk12) |
| 06/28/2007 | US20070148173 Treatment of Acute Lung Injury, Fibrosis and Metastasis with Antagonists of Alpha V Beta 6 |
| 06/28/2007 | US20070148161 Biopolymer membrane and methods for its preparation |
| 06/28/2007 | US20070148160 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 06/28/2007 | US20070148159 Use of crotoxin as an analgesic - CIP |
| 06/28/2007 | US20070148158 Rationally designed heparinases derived from heparinase II |
| 06/28/2007 | US20070148157 Chondroitinase ABC I polynucleotides |
| 06/28/2007 | US20070148156 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
| 06/28/2007 | US20070148155 Use of alkaline phosphatase to maintain healty tissue mass in mammals |
| 06/28/2007 | US20070148154 Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs |
| 06/28/2007 | US20070148153 Controlled release pharmaceutical compositions for acid-labile drugs |
| 06/28/2007 | US20070148152 Process for the manufacture and use of pancreatin micropellet cores |
| 06/28/2007 | US20070148151 Processes for the manufacture and use of pancreatin |
| 06/28/2007 | US20070148150 MKK7 activation inhibitor |
| 06/28/2007 | US20070148143 Human cytokine receptor |
| 06/28/2007 | US20070148140 Compositions and methods to enhance viability and function of islet cells |
| 06/28/2007 | US20070148131 Methods and compositions for needleless delivery of binding partners |
| 06/28/2007 | US20070148130 Native TRRE: protein implicated in TNF receptor shedding for treating arthritis and inflammation |
| 06/28/2007 | US20070148129 Therapeutic agents and uses therefor |
| 06/28/2007 | US20070148091 Peptides and compounds that bind to a receptor |
| 06/28/2007 | US20070148090 Per (3,6-anhydro) cyclodextrin derivatives, preparation thereof and use thereof for transporting metal elements to biological targets or for decontaminating biological targets of fluids |